Miguel García Deltoro

ORCID: 0000-0002-5969-1059
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • HIV/AIDS drug development and treatment
  • Hepatitis B Virus Studies
  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • COVID-19 Clinical Research Studies
  • HIV-related health complications and treatments
  • Long-Term Effects of COVID-19
  • Liver Disease and Transplantation
  • Biochemical and Molecular Research
  • SARS-CoV-2 and COVID-19 Research
  • Drug-Induced Hepatotoxicity and Protection
  • Sex work and related issues
  • Herpesvirus Infections and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Mosquito-borne diseases and control
  • Viral Infections and Immunology Research
  • Poisoning and overdose treatments
  • Virology and Viral Diseases
  • Poxvirus research and outbreaks
  • Dermatological and COVID-19 studies
  • Hepatitis Viruses Studies and Epidemiology
  • Alcohol Consumption and Health Effects

Hospital General Universitario De Valencia
2016-2025

Universitat de València
2021-2025

Brighton and Sussex Medical School
2023

Queen Mary University of London
2023

Yale University
2023

Imperial College London
2023

Weatherford College
2022

Hospital Universitari de Vic
2021-2022

Sociedad Española de Medicina Interna
2018

Hospital Regional Universitario de Málaga
2016

A Howe Chaturaka Rodrigo Evan B. Cunningham Mark W. Douglas Julia Dietz and 95 more Jason Grebely Stephanie Popping Javier Alejandro Sfalcin Miłosz Parczewski Christoph Sarrazin Adolfo de Salazar Ana Fuentes Murat Sayan Josep Quer Midori Kjellin Hege Kileng Orna Mor Johan Lennerstrand Slim Fourati V.C. Di Maio Vladimir Chulanov Jean‐Michel Pawlotsky P. Richard Harrigan Francesca Ceccherini‐Silberstein Féderico García Marianne Martinello Gail Matthews Fay Fabián Fernando Juan Ignacio Esteban Beat Müllhaupt Julian Schulze zur Wiesch Peter Buggisch Christoph Neumann‐Haefelin Thomas Berg Christoph P. Berg Jörn M. Schattenberg Christophe Moreno Rudolf Stauber Andrew R. Lloyd Gregory J. Dore Tanya Applegate Juan Ignacio Damir García‐Cehic Josep Gregori Francisco Rodríguez‐Frías Ariadna Rando‐Segura Yael Gozlan M. Angélico Massimo Andreoni Sergio Babudieri Ada Bertoli Valeria Cento Nicola Coppola Antonio Craxı̀ Stefania Paolucci Giustino Parruti C. Pasquazzi Carlo Federico Perno Elisabetta Teti C. Vironet Anders Lannergård Ann‐Sofi Duberg Soo Aleman Tore Jarl Gutteberg Alexandre Soulier Aurélie Gourgeon Stéphane Chevaliez Stanislas Pol Fabrice Carrat Dominique Salmon‐Céron Rolf Kaiser Elena Knopes Perpétua Gómes Rob de Kneght Bart Rijnders Mario Poljak Maja M. Lunar Rafael Usubillaga Carole Seguin‐Devaux Enoch Tay Caroline Wilson Dao Sen Wang Jacob George Jen Kok Ana Belén Pérez Natalia Chueca Miguel García Deltoro Ana Martínez-Sapiña María Magdalena Lara-Pérez Silvia García‐Bujalance Teresa Aldámiz‐Echevarría Francisco Jesús Vera-Méndez Juan A. Pineda Marta Casado J.M. Pascasio Javier Salmerón Juan Carlos Alados Antonio Poyato Francisco Téllez António Rivero‐Juarez

•An international cohort of 3,355 patients with hepatitis C from 22 countries was evaluated for drug resistance following DAA therapy.•Nearly all harbored drug-resistant variants after treatment failure, over 2/3 having against ≥2 classes.•Pathways to included enrichment highly resistant and selection multiple variants.•Previously unrecognized in who failed NS5A inhibitors were identified at high frequencies.•Resistance frequent older people cirrhosis those infected genotypes 1b 4 failure....

10.1016/j.jhepr.2022.100462 article EN cc-by-nc-nd JHEP Reports 2022-02-24
Meghan E. Sise Jose Ramon Santos Jason D. Goldman Katherine R. Tuttle J. Pedro Teixeira and 95 more A. F. Seibert Yiannis Koullias Joe Llewellyn S. P. Regan Yang Zhao Hailin Huang Robert H. Hyland Anu Osinusi Helen Winter Rita Humeniuk Henry N. Hulter Robert Gottlieb Dahlene N. Fusco Rita Birne Fernando F. Stancampiano Claudia R. Libertin Catherine B. Small Markus Plate Mark McPhail Rosa Ballesteros Rita Birne Luís Malheiro Gil Silva João Paulo Correia Ana Carlota Vida André Silva Antonio Carujo Moncef Belhassen‐García Jordi Carratala Fernandez Gabriela Abelenda-Alonso Josep M. Cruzado Alexander Rombauts Diego Sandoval Miguel García Deltoro Fransesc Puchades Gimeno Neus Gómez‐Muñoz Maria Martínez Roma Juan Horcajada Gallego Castañeda Pablo Padilla Urrea Silvia Rial Crestelo Sergio Santos Fernandez David Ramon Jose Susanna Benet Rosa Benítez Carmen Bracke Anna Chamorro Sergio España Fredzzia Graterol Gemma Lladós C. López Lourdes Mateu Roger Paredes Boris Rebollo Alba Romero Laura Soldevila Elena Abad Anna Chamorro Alba San José Álex Soriano Mark McPhail Nicholas Medjeral‐Thomas Suzana Margareth Lobo Igor Z. Abolnik Anjali Acharya Leland Allen Keith Bellovich Mary Jane Burton Miriam L. Cameron Gerard J. Criner Lii-Yoong H Criner Joseph Lambert Marium Rashid Heidi Shore-Brown George A. Diaz David W. Dougherty Nathaniel Erdmann Dahlene N. Fusco Jason D. Goldman William R. Berrington Christine M. Logar Nidyanandh Vadivel Allison Everett Gonzalez Suarez Maria Lourdes Robert Gottlieb Mezgebe Berhe Gates B. Colbert Christopher Hebert Ankit Mehta Cedric W. Spak Lorie Estrada Richard Vargas Jennifer H. Choe Alex Pham Lynn Mason

Few antiviral therapies have been studied in patients with coronavirus disease 2019 (COVID-19) and kidney impairment. Herein, the efficacy, safety, pharmacokinetics of remdesivir, its metabolites, sulfobutylether-β-cyclodextrin excipient were evaluated hospitalized COVID-19 severe In REDPINE, a phase 3, randomized, double-blind, placebo-controlled study, participants aged ≥12 years for pneumonia acute injury, chronic disease, or failure randomized 2:1 to receive intravenous remdesivir (200...

10.1093/cid/ciae333 article EN cc-by-nc-nd Clinical Infectious Diseases 2024-06-24

10.1016/j.jhep.2020.11.017 article EN Journal of Hepatology 2020-11-19

This was a study of monkeypox-infected patients in tertiary care center Spain describing the epidemiologic, clinical, and microbiologic features 49 patients. Background Monkeypox is previously rare viral zoonosis affecting predominantly African continent. Since May 2022, an increasing number cases with no known epidemiologic link to Africa have been reported for first time rest world. Methods We described clinical characteristics all attended at our until August 9 confirmed diagnosis...

10.1097/olq.0000000000001734 article EN Sexually Transmitted Diseases 2022-11-11

Abstract Background Cabotegravir + rilpivirine (CAB RPV) administered via intramuscular gluteal injections is the first complete long-acting regimen for maintaining human immunodeficiency virus type 1 (HIV-1) virologic suppression. We present substudy results on short-term repeat CAB RPV thigh in participants with ≥3 years of experience administration during ATLAS–2M study. Methods Substudy phases included screening, injection (day 1–week 16), and return to (week 16–week 24). The schedule...

10.1093/cid/ciae620 article EN cc-by Clinical Infectious Diseases 2025-01-07

Hepatitis delta virus (HDV) is the most aggressive form of chronic viral hepatitis, yet substantial knowledge gaps exist regarding its epidemiology and optimal diagnostic workflows. From February 2019 to March 2022, an HBV screening project was conducted across various healthcare settings in Valencia, Spain. This included twenty-six primary care centers, six sexual reproductive health three mental addiction treatment selected hospital departments, outpatient clinics, a penitentiary center. A...

10.1038/s41598-025-91765-8 article EN cc-by-nc-nd Scientific Reports 2025-03-04

Background Pre-exposure prophylaxis (PrEP) is an effective and cost-effective strategy for HIV prevention. Spain carried out implementation study in order to assess the feasibility of implementing PrEP programmes within its heterogeneous health system. Methods Observational longitudinal conducted on four different types health-care setting: a community centre (CC), sexually transmitted infections clinic (STIC), hospital-based unit (HBHIVU) STI (HBSTIU). We recruited gay, bisexual other men...

10.1371/journal.pone.0246129 article EN cc-by PLoS ONE 2021-02-08

Abstract Our study assessed the characteristics of people living with HIV (PLWH) detected via opportunistic screening in Valencia (Spain) to determine diagnoses potentially missed under a more restrictive, indicator-condition diagnostic strategy. We conducted retrospective analysis electronic health records 97 PLWH diagnosed between April 2019 and August 2022. The main outcomes reported were patient CD4 + T cell count, known risk factors at diagnosis, opportunities for defined as failure...

10.1007/s10900-024-01326-9 article EN cc-by Journal of Community Health 2024-02-26

Long-acting injectable antiretroviral therapy has been shown to be non-inferior daily oral in clinical trials and may soon become part of care. While most trial participants date have men, approximately one quarter ongoing Phase 3 are women offering an important opportunity understand how long-acting is perceived experienced by women. We conducted in-depth interviews with 80 people living HIV participating 2 the USA Spain. Fifteen percent (12/80) interviewed were Interviews audio-recorded,...

10.1080/13691058.2020.1752397 article EN Culture Health & Sexuality 2020-05-21

The fibrogenesis analysis in quimeric CCR1 and CCR5 mice revealed that mediates its pro-fibrogenic effects hepatic cells promoting stellate cells. blockage of co-receptors could preserve the progression fibrosis HIV/HCV co-infected patients.To evaluate beneficial on patients are antiretroviral therapy (ART) with co-receptor antagonists.A multicentre, retrospective pilot study evaluation at mid- long-term by non-invasive methods a cohort Valencian Community (Spain) received ART antagonist....

10.7448/ias.17.4.19643 article EN Journal of the International AIDS Society 2014-11-01
Adolfo de Salazar Julia Dietz V.C. Di Maio Johannes Vermehren Stefania Paolucci and 95 more Beat Müllhaupt Nicola Coppola Joaquín Cabezas Rudolf Stauber Massimo Puoti Juan Ignacio Arenas Ruiz Tapiador Christiana Graf M. Aragri Miguel A. Jiménez Annapaola Callegaro Juan Manuel Pascasio Acevedo Manuel Alberto Macías Rodríguez José Miguel Rosales Zábal Valeria Micheli Miguel García Deltoro Francisco Téllez Féderico García Christoph Sarrazin Francesca Ceccherini‐Silberstein Tobias Götze Ali Canbay Kerstin Port Markus Cornberg Michael Manns Lars Reinhardt Volker Ellenrieder Eugen Zizer Nektarios Dikopoulos Johanna Backhus Thomas Seufferlein Susanne Beckebaum S Hametner R Schöfl Claus Niederau P. Schlee M. Dreck B. Görlitz Holger Hinrichsen Barbara Seegers M. Jung R. Link Stefan Mauss V. Meister Eiko Schnaitmann C. Sick Karl‐Georg Simon K. J. Schmidt Massimo Andreoni Antonio Craxı̀ P. Giaccone Carlo Federico Perno Maurizio Zazzi Ada Bertoli M. Angélico Chiara Masetti V. Giannelli San Camillo Paola Begini A. De Santis Gloria Taliani Miriam Lichtner Barbara Rossetti C. Caudai Raffaele Cozzolongo S De Bellis Mario Starace Carmine Minichini Gianfranco Gaeta Mariantonietta Pisaturo Vincenzo Messina Chiara Dentone Bianca Bruzzone Simona Landonio C. Magni Marco Merli Elisabetta De Gasperi Granda Ospedale Maggiore Policlinico Hamid Hasson Enzo Boeri Ilaria Beretta Chiara Molteni A Manzoni Elena Maffezzini Nicoletta Dorigoni Lorenza Guella Tobias Götze Ali Canbay Kerstin Port Markus Cornberg Michael Manns Lars Reinhardt Volker Ellenrieder Eugen Zizer Nektarios Dikopoulos Johanna Backhus Thomas Seufferlein

Abstract Objectives To investigate resistance-associated substitutions (RASs) as well retreatment efficacies in a large cohort of European patients with failure glecaprevir/pibrentasvir. Methods Patients were identified from three Resistance Reference centres Spain, Italy and Germany. Sequencing NS3, NS5A NS5B was conducted associated resistance to direct antiviral agents analysed. Clinical virological parameters documented retrospectively evaluated. Results We evaluated 90...

10.1093/jac/dkaa304 article EN Journal of Antimicrobial Chemotherapy 2020-06-20

ABSTRACT Background Nonalcoholic fatty liver disease (NAFLD) is an increasing concern for people living with HIV (PLWH). However, information on the impact of NAFLD prognosis PLWH very scarce. Aims To investigate influence overall and liver‐related mortality in PLWH. Methods followed three Spanish centres were included a prospective cohort at date first transient elastography evaluation. Survival data recorded, causes death centrally monitored. The risk all‐cause was evaluated by applying...

10.1111/apt.18413 article EN cc-by-nc-nd Alimentary Pharmacology & Therapeutics 2024-11-27
Coming Soon ...